AIM
GMED icon

Acrospire Investment Management’s Globus Medical GMED Stock Holding History

Acrospire Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,162
Closed -$72K – 586
2017
Q2 		$72K Buy
2,162
+1,200
+125% +$37.7K 0.07% 498
2017
Q1 		$28K Sell
962
-2,700
-74% -$73.7K 0.02% 1398
2016
Q4 		$91K Sell
3,662
-1,738
-32% -$39.5K 0.04% 994
2016
Q3 		$122K Buy
5,400
+1,300
+32% +$30.6K 0.08% 391
2016
Q2 		$98K Buy
4,100
+1,000
+32% +$24K 0.07% 467
2016
Q1 		$74K Buy
+3,100
New +$75.8K 0.05% 567

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Acrospire Investment Management's GMED Position: Q3 2017 in Review

Acrospire Investment Management sold out of Globus Medical (GMED) in Q3 2017, closing a stake of 2,162 shares — an estimated $72K sold.

Acrospire Investment Management first reported a position in GMED in Q1 2016 and held it in 6 quarters. The position peaked at $122K in Q3 2016. 253 funds tracked by Wall St. Rank hold GMED as of Q3 2017.

  • Acrospire Investment Management reported no remaining Globus Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,162 Globus Medical shares in Q3 2017, an estimated $72K.
  • Acrospire Investment Management first reported a position in Globus Medical in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Globus Medical position peaked at $122K in Q3 2016.
  • 253 funds tracked by Wall St. Rank held Globus Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.